Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: A mechanism for its antioxidant ability

Lipids

Volumn 48, Issue 6, 2013, Pages 569-578

  Kotosai, Mari ^a   Shimada, Sachiko ^a   Kanda, Mai ^a   Matsuda, Namiko ^a   Sekido, Keiko ^a,b   Shimizu, Yoshibumi ^a   Tokumura, Akira ^a   Nakamura, Toshiyuki ^a   Murota, Kaeko ^a,c   Kawai, Yoshichika ^a,d   Terao, Junji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Apolipoprotein A 1; Atherosclerosis; HDL; Nonesterified fatty acid hydroperoxides; Oxidized LDL; Platelet activating factor acetyl hydrolase

Indexed keywords

13 HYDROPEROXYOCTADECADIENOIC ACID; 13 HYDROXYOCTADECADIENOIC ACID; APOLIPOPROTEIN A1; CHOLESTERYL ESTER HYDROPEROXIDE; COPPER ION; ESTERASE INHIBITOR; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LIPID HYDROPEROXIDE; LYSOPHOSPHATIDYLCHOLINE; NONESTERIFIED FATTY ACID HYDROPEROXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE HYDROPEROXIDE; PLATELET ACTIVATING FACTOR ACETYLHYDROLASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; OXIDATION; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANTIOXIDANTS; APOLIPOPROTEIN A-I; FATTY ACIDS, NONESTERIFIED; HUMANS; LIPID PEROXIDES; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; OXIDATION-REDUCTION;

EID: 84878563314     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3779-1     Document Type: Article

References (45)

1. Scanu AM (2008) HDL: bringing past and present with a look at the future. FASEB J 2:4044-4054
2. Barter PJ, Rye K-A (2007) HDL and atherosclerosis. In: Fielding CJ (ed) High-density lipoproteins: from basic to clinical aspects. Wiley-VCH Weinheim, Germany, pp 491-505
3. Witztum JL, Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792
4. Glass CK, Witztum JL (2001) Atherosclerosis; the road ahead. Cell 104:503-516
5. Sato K, Niki E, Shimasaki H (1990) Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys 279:402-405
6. Stocker R, Bowry VW, Frei B (1991) Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 88:1646-1650
7. Tokumura A, Sumida T, Toujima M, Kogure K, Fukuzawa K (2000) Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis. Bio Factors 13:29-33
8. Niki E (2009) Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 47:469-484
9. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med 320:915-924
10. Baynes JW, Thorpe SR (2000) Glycosidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708-1716
11. Bowry VW, Stanley KK, Stocker R (1992) High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 89:10316-10320
12. Podrez E (2010) Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin Exp Pharmacol Physiol 37:719-725
13. 2, platelet activating factor-acetylhydrolase. Atherosclerosis S3:57-68
14. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M (1995) Protective effect of high density lipoprotein associated paraoxonase. J Clin Invest 96:2882-2891
15. Aviram M, Rosenbla M (2004) Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37:1304-1316
16. Marathe GK, Zimmerman GA, McIntyre TM (2003) Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. J Biol Chem 278:3937-3947
17. Kriska TG, Marathe G, Schmidt JC, Mclntyre TM, Girotti AW (2007) Phospholipase action of platelet-activating factor acetylhydrolase, but not paraoxonase-1, on long fatty acyl chain phospholipid hydroperoxides. J Biol Chem 282:100-108
18. Garner B, Waldeck RA, Witting PK, Rye K-A, Stocker R (1998) Oxidation of high density lipoprotein II. Evidence for direct reduction of lipid hydroperoxides by methionine residue of apolipoproteins AI and AII. J Biol Chem 273:6088-6095
19. Nabav M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM (2000) Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 2 and step 3. J Lipid Res 41:1495-1508
20. Amarenco P, Labreuche J, Toubou P-J (2008) High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis 196:489-496
21. Terao J, Asano I, Matsushita S (1985) Preparation of hydroperoxy and hydroxyl derivatives of rat liver phosphatidylcholine and phosphatidylethanolamine. Lipids 20:312-317
22. Yoshida Y, Ito N, Shimakawa S, Niki E (2003) Susceptibility of plasma lipids to peroxidation. Biochem Biophys Res Comm 305:747-753
23. Terao J, Miyoshi M, Miyamoto S (2001) Thin-layer chromatography blotting for the fluorescence detection of phospholipid hydroperoxides and cholesteryl ester hydroperoxides. J Chromatogr B 765:199-203
24. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302-310
25. Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234:466-468
26. Terao J, Nagao A, Yuki H, Itoh Y (1993) Reduction of fatty acid hydroperoxides by human parotid saliva. Lipids 28:121-124
27. Murota K, Hotta A, Ido H, Kawai Y, Moon J-H, Sekido K, Hayashi H, Inakuma T, Terao J (2007) Antioxidant capacity of albumin-bound quercetin metabolites after onion consumption in humans. J Med Invest 54:370-374
28. da Silva E, Tsushida T, Terao J (1998) Inhibition of mammalian 15-lipoxygenase-dependent lipid peroxidation in low-density lipoprotein by quercetin and quercetin monoglucosides. Arch Biochem Biophys 349:313-320
29. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
30. Proudfoot JM, Barden AE, Loke WM, Croft KD, Puddey IB, Mori TA (2009) HDL is the major lipoprotein carrier of plasma F2-isoprostanes. J Lipid Res 50:716-722
31. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem 37:911-917
32. Kriska T, Girotti AW (2004) Separation of peroxidized phospholipids using high-performance thin layer chromatography with tetramethyl-p-phenylenediamine detection. Anal Biochem 327:97-106
33. Taki T, Kasama T, Hand S, Ishikawa D (1994) A simple and quantitative purification of glycosphingolipids and phospholipids by thin-layer chromatography blotting. Anal Biochem 223:232-238
34. Browne RW, Armstrong D (2000) HPLC analysis of lipid-derived polyunsaturated fatty acid peroxidation products in oxidatively modified human plasma. Clin Chem 46:6829-6836
35. Wang X-S, Shao B, Oda MN, Heinecke JW, Mahler S, Stocker R (2009) A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-1 in HDL. J Lipid Res 50:586-594
36. Minami Y, Yokoyama K, Bando N, Kawai Y, Terao J (2008) Occurrence of singlet oxygen oxygenation of oleic acid and linoleic acid in the skin of live mice. Free Radic Res 42:197-204
37. Panzenbock U, Stocker R (2005) Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoprotein. Biochim Biophys Acta 1703:171-181
38. Mashima R, Yoshimara S, Yamamoto Y (1999) Reduction of lipid hydroperoxides by apolipoprotein B-100. Biochem Biophys Res Comm 259:185-189
39. Noguchi N, Numano R, Kaneda H, Niki E (1998) Oxidation of lipids in low density lipoprotein particles. Free Radic Res 29:43-52
40. Burkitt MJ (2001) A critical review of the chemistry of copper-dependent low-density lipoprotein oxidation: roles of lipid hydroperoxides, α-tocopherol, thiols and ceruloplasmin. Arch Biochem Biophys 394:117-135
41. Karasawa K (2006) Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim Biophys Acta 1761:1359-1372
42. Pankhurst G, Wang XL, Wilcken DE, Baernthaler G, Panzenbock U, Raftery M, Stocker R (2003) Characterization of specifically oxidized apolipoproteins in mild oxidized high density lipoprotein. J Lipid Res 44:349-355
43. Kontush A, Chapman MJ (2010) Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol 21:312-318
44. Kim H-Y, Gladyshev VN (2007) Methionine sulfoxide reductase:selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem J 407:321-329
45. Moskovitz J, Oien DB (2010) Protein carbonyl and the methionine sulfoxide reductase system. Antiox Redox Signal 12:405-415